Page last updated: 2024-09-05

lenalidomide and Symptom Cluster

lenalidomide has been researched along with Symptom Cluster in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Cheng, CE; Cheng, M; Liang, B; Lor, M1
Liang, SH; Yeh, SP1
Cazzola, M1
Aue, G; Boss, C; Gibellini, F; Hughes, T; Keyvanfar, K; McCoy, JP; Njuguna, N; Pittaluga, S; Samsel, L; Soto, S; Tian, X; Valdez, J; Vire, B; Wiestner, A; Wilson, WH1
Abonour, R; Knox, K; Smith, P; Thornburg, A; Twigg, HL1

Trials

1 trial(s) available for lenalidomide and Symptom Cluster

ArticleYear
Lenalidomide-induced upregulation of CD80 on tumor cells correlates with T-cell activation, the rapid onset of a cytokine release syndrome and leukemic cell clearance in chronic lymphocytic leukemia.
    Haematologica, 2009, Volume: 94, Issue:9

    Topics: Aged; Antineoplastic Agents; B7-1 Antigen; Cytokines; Female; Humans; Lenalidomide; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocyte Activation; Male; Middle Aged; Syndrome; Thalidomide; Time Factors; Up-Regulation

2009

Other Studies

4 other study(ies) available for lenalidomide and Symptom Cluster

ArticleYear
TEMPI Syndrome With Progressive Telangiectasias Associated With Pulmonary Deterioration.
    JAMA dermatology, 2020, 12-01, Volume: 156, Issue:12

    Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Bortezomib; Drug Therapy, Combination; Humans; Lenalidomide; Lung; Male; Middle Aged; Paraproteinemias; Polycythemia; Respiratory Insufficiency; Syndrome; Telangiectasis

2020
Relapsed multiple myeloma as TEMPI syndrome with good response to salvage lenalidomide and dexamethasone.
    Annals of hematology, 2019, Volume: 98, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Humans; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Polycythemia; Recurrence; Salvage Therapy; Syndrome; Telangiectasis

2019
Myelodysplastic syndrome with isolated 5q deletion (5q- syndrome). A clonal stem cell disorder characterized by defective ribosome biogenesis.
    Haematologica, 2008, Volume: 93, Issue:7

    Topics: Adult; Blood Platelets; Chemistry, Pharmaceutical; Chromosome Deletion; Chromosomes, Human, Pair 5; Clinical Trials as Topic; Humans; In Situ Hybridization, Fluorescence; Karyotyping; Lenalidomide; Male; Myelodysplastic Syndromes; Stem Cells; Syndrome; Thalidomide

2008
Hypersensitivity pneumonitis-like syndrome associated with the use of lenalidomide.
    Chest, 2007, Volume: 131, Issue:5

    Topics: Alveolitis, Extrinsic Allergic; Antineoplastic Agents; Dexamethasone; Drug Therapy, Combination; Dyspnea; Female; Fever; Humans; Lenalidomide; Middle Aged; Multiple Myeloma; Syndrome; Thalidomide

2007